Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Medicus Pharma (NASDAQ:MDCX) through any online brokerage.
Other companies in Medicus Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Medicus Pharma has a consensus price target of $14.50.
The stock price for Medicus Pharma (NASDAQ: MDCX) is $0.1618 last updated October 2, 2026 at 4:20 PM EDT.
There are no upcoming dividends for Medicus Pharma.
Medicus Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Medicus Pharma.
Medicus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.